| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.18▲ | 2.18▲ | 2.18▲ | 2.24▼ | 2.23▼ |
| MA10 | 2.20▲ | 2.20▲ | 2.21▼ | 2.31▼ | 2.18▲ |
| MA20 | 2.23▼ | 2.26▼ | 2.28▼ | 2.22▼ | 2.24▼ |
| MA50 | 2.30▼ | 2.28▼ | 2.28▼ | 2.20▼ | 4.19▼ |
| MA100 | 2.26▼ | 2.20▲ | 2.19▲ | 2.25▼ | 3.97▼ |
| MA200 | 2.19▲ | 2.20▲ | 2.24▼ | 4.47▼ | 4.51▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.010▼ | -0.015▼ | -0.005▼ | 0.125▲ |
| RSI | 44.599▼ | 45.097▼ | 45.356▼ | 46.543▼ | 38.675▼ |
| STOCH | 25.000 | 16.667▼ | 13.889▼ | 32.190 | 37.090 |
| WILL %R | -50.000 | -57.143 | -63.636 | -85.135▼ | -74.572 |
| CCI | -24.609 | -41.758 | -56.710 | -87.910 | -34.183 |
|
Monday, September 14, 2026 05:00 AM
Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced the initiation of BLOOM, a Phase 3 study evaluating LPCN 1154 ...
|
|
Friday, September 11, 2026 03:46 AM
Lipocine ( ) has shared an update. Lipocine Inc., a specialty biopharmaceutical company listed on NASDAQ, develops novel orally delivered therapeutics targeting large, unmet-need ...
|
|
Thursday, September 10, 2026 05:00 AM
Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company management will present and meet with investors at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/09/26 | 2.20 | 2.24 | 2.15 | 2.185 | 50,450 |
| 14/09/26 | 2.20 | 2.2699 | 2.15 | 2.22 | 27,319 |
| 11/09/26 | 2.29 | 2.30 | 2.25 | 2.27 | 10,397 |
| 10/09/26 | 2.315 | 2.345 | 2.25 | 2.25 | 9,384 |
| 09/09/26 | 2.34 | 2.3525 | 2.25 | 2.25 | 4,810 |
| 08/09/26 | 2.39 | 2.40 | 2.345 | 2.36 | 21,136 |
| 04/09/26 | 2.4206 | 2.4799 | 2.3612 | 2.45 | 22,720 |
| 03/09/26 | 2.41 | 2.50 | 2.32 | 2.42 | 26,454 |
| 02/09/26 | 2.22 | 2.39 | 2.22 | 2.355 | 34,150 |
| 01/09/26 | 2.19 | 2.30 | 2.1831 | 2.30 | 10,003 |
|
|
||||
|
|
||||
|
|